Physician profile
Thomas E Sonnanstine
NPI 1396852927
$144,400.81
in general payments reported to CMS, 2019-2025
15 companies · $36K in 2025
The $36K reported for 2025 was more than what 98% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $26K · 2020: $10K · 2021: $38K · 2022: $6,206 · 2023: $3,168 · 2024: $25K · 2025: $36K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $45K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $9,350 · Travel and Lodging: $5,988 · Food and Beverage: $3,291 · Education: $305 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $45,013.44 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $9,350.00 |
| Travel and Lodging | $5,988.49 |
| Food and Beverage | $3,291.12 |
| Education | $305.00 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $82,170.97 | 2019-2025 | Echelon Endopath, Echelon; Endopath, Echelon Circular |
| Medtronic, INC. | $23,170.13 | 2021-2024 | Signia, Situate, Ligasure |
| Ethicon US, LLC | $22,841.80 | 2019-2025 | Echelon Circular, Harmonic, Echelon Endopath |
| Ethicon Endo-Surgery INC. | $4,793.47 | 2020-2025 | Echelon Endopath, Harmonic |
| Ethicon INC. | $3,450.00 | 2021-2023 | Endopath Xcel |
| Cook Incorporated | $2,800.00 | 2019 | |
| Intuitive Surgical, INC. | $2,014.14 | 2023-2024 | Da Vinci Surgical System |
| Cook Biotech Incorporated | $2,000.00 | 2019 | |
| Covidien Lp | $606.04 | 2019-2020 | |
| Baxter Healthcare | $263.51 | 2019 | |
| Cook Medical LLC | $106.75 | 2019-2020 | |
| Olympus America INC. | $80.93 | 2019 | |
| Redhill Biopharma INC. | $43.02 | 2021 | |
| Daiichi Sankyo INC. | $30.83 | 2019 | |
| Currax Pharmaceuticals LLC | $29.22 | 2025 | Contrave |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Sonnanstine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.